Business Context and Reporting Period
This Form 8-K Current Report was filed by Keros Therapeutics, Inc. on June 3, 2024. The filing serves as a Regulation FD disclosure regarding an upcoming corporate event rather than a periodic financial report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is an event notification and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document solely announces a scheduled presentation by company leadership.
Guidance, Outlook, and Management Commentary
Upcoming Event: Jasbir Seehra, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the Goldman Sachs 45th Annual Healthcare Conference on Monday, June 10, 2024, at 2:40 p.m. Eastern time.
Legal Disclaimer: The information in this report and the accompanying press release (Exhibit 99.1) is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. It is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the date and time of the Goldman Sachs 45th Annual Healthcare Conference presentation (June 10, 2024, 2:40 p.m. ET).
- Review the full text of the press release attached as Exhibit 99.1 for any additional details on the presentation topic.
- Confirm that no financial data or forward-looking guidance was included in this specific 8-K filing.